OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases
Xiaoyu Wang, Yunxiang Zhou, Qiannan Gao, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-17
Open Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

miRNA Studies in Glaucoma: A Comprehensive Review of Current Knowledge and Future Perspectives
Margarita Dobrzycka, Anetta Sulewska, Przemysław Biecek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14699-14699
Open Access | Times Cited: 16

The roles of extracellular vesicles in major depressive disorder
Ying Li, Yan Gui, Miaomiao Zhao, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 15

New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders
Jiale Liu, Wenjie Duan, Yushu Deng, et al.
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 3
Open Access | Times Cited: 14

Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
Y. Ma, Lan Zhao
Behavioural Neurology (2023) Vol. 2023, pp. 1-24
Open Access | Times Cited: 14

Exosomes: A missing link between chronic systemic inflammation and Alzheimer’s disease?
Mehmet Ozansoy, Houda Mikati, Halil Aziz Velioğlu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114161-114161
Open Access | Times Cited: 13

Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach—A Comprehensive Narrative Review
Sara Uceda, Víctor Echeverry‐Alzate, Manuel Reiriz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13294-13294
Open Access | Times Cited: 13

Exosome-derived microRNAs: emerging players in vitiligo
Wenquan li, Yaobin Pang, Qingying He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Role of Exosomes in Brain Diseases
Nan Zhang, Fengling He, Ting Li, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 31

Exosome in Crosstalk between Inflammation and Angiogenesis: A Potential Therapeutic Strategy for Stroke
Yongdan Cun, Yaju Jin, Danli Wu, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 22

The antioxidant effects of hedysarum polybotrys polysaccharide in extending lifespan and ameliorating aging-related diseases in Drosophila melanogaster
Shipei Yang, Minghui Xiu, Xu Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 241, pp. 124609-124609
Closed Access | Times Cited: 11

Exosomal Dynamics and Brain Redox Imbalance: Implications in Alzheimer’s Disease Pathology and Diagnosis
Aritri Bir, A. C. GHOSH, Aman Chauhan, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 316-316
Open Access | Times Cited: 4

Exosomal microRNAs as potential biomarkers and therapeutic targets in corneal diseases.
Swati Arora, Nagendra Verma
PubMed (2024) Vol. 30, pp. 92-106
Closed Access | Times Cited: 4

Microglia-derived exosomes selective sorted by YB-1 alleviate nerve damage and cognitive outcome in Alzheimer’s disease
Hong Wei, Zhuzhi Zhu, Yuhao Xu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

Exosomal MicroRNAs modulate the cognitive function in fasudil treated APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer’s disease
Yuqing Yan, Ye Gao, Gajendra Kumar, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 7, pp. 1335-1351
Open Access | Times Cited: 4

MicroRNAs regulation in Parkinson’s disease, and their potential role as diagnostic and therapeutic targets
Nour Shaheen, Ahmed Shaheen, Mahmoud Osama, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4

Impact of LITAF on Mitophagy and Neuronal Damage in Epilepsy via MCL‐1 Ubiquitination
Fu‐Li Min, Zhaofei Dong, Shui-Sheng Zhong, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access

Sulforaphane: An emerging star in neuroprotection and neurological disease prevention
Na Wu, Zhongping Luo, Rui Deng, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116797-116797
Closed Access

The Emerging Role of MicroRNAs in Nasal Inflammatory Diseases and Tumors: From Bench to Bedside
Antonella Loperfido, Carlo Cavaliere, Bruno Fionda, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 295-295
Open Access

Predictors of delayed encephalopathy after acute carbon monoxide poisoning: a literature review
Yongjing Wang, Zunzhen Zhou, Dailiang Zhang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access

Advances in Research on Exosomal miRNAs in Central Nervous System Diseases
Guangli Feng, Xiaoqian Lan, Shiyi Qin, et al.
ASN NEURO (2025) Vol. 17, Iss. 1
Open Access

Targeted miRNA Delivery in Epilepsy: Mechanisms, Advances, and Therapeutic Potential
Mukul Shyam, Oveyaa Bm, Prathap Srirangan, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Nanoparticles induced neurotoxicity
Divya Bajpai Tripathy, Subhalaxmi Pradhan, Anjali Gupta, et al.
Nanotoxicology (2025), pp. 1-28
Closed Access

Mitochondrial microRNAs (mitomiRs) as emerging biomarkers and therapeutic targets for chronic human diseases
Andrea Méndez-García, Marely Abigail García-Mendoza, Carmila Patricia Zárate-Peralta, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access

Scroll to top